• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童复杂感染患者万古霉素给药剂量的评估。

An evaluation of vancomycin dosing for complicated infections in pediatric patients.

作者信息

Durham Spencer H, Simmons Marroyln L, Mulherin Diana W, Foland Jason A

机构信息

Auburn University Harrison School of Pharmacy, Auburn, Alabama;

St. Joseph's Children's Hospital, Tampa, Florida;

出版信息

Hosp Pediatr. 2015 May;5(5):276-81. doi: 10.1542/hpeds.2014-0081.

DOI:10.1542/hpeds.2014-0081
PMID:25934812
Abstract

OBJECTIVE

To determine the incidence with which a vancomycin dosing regimen of 15 mg/kg per dose every 6 hours achieves steady-state trough concentrations of 15 to 20 mg/L in pediatric patients with complicated infections.

METHODS

We performed a retrospective chart review for patients admitted to our children's hospital between July 1, 2009, and June 30, 2011. Patients were included if they were between 1 month and 18 years of age, had at least 1 steady-state vancomycin trough obtained, received an initial vancomycin dose of 15 mg/kg per dose every 6 hours, and were being treated for a diagnosis of meningitis, pneumonia, osteomyelitis, bacteremia/sepsis, or endocarditis.

RESULTS

Seventy-four patients were enrolled, mean age of 4.2±3.9 years and weight of 17.0±11.2 kg. Five (6.8%) patients obtained an initial trough of 15 to 20 mg/L. Patients between 1.0 and 5.9 years of age were significantly less likely to achieve an initial trough of 15 to 20 mg/L compared with other age groups evaluated (P=.041). Thirty-four patients with initial subtherapeutic troughs received a dose adjustment and a follow-up vancomycin trough. Of these patients, 15 (44.1%) achieved a trough between 15 and 20 mg/L. The median dose for patients achieving a therapeutic trough at any point during the study was 80 mg/kg per day.

CONCLUSIONS

A vancomycin dosing regimen of 15 mg/kg per dose every 6 hours is not likely to achieve a trough concentration of 15 to 20 mg/L in pediatric patients with complicated infections. An initial regimen of 80 mg/kg per day for these patients may be more likely to result in therapeutic steady-state concentrations of vancomycin.

摘要

目的

确定每6小时一次、每次15mg/kg的万古霉素给药方案在患有复杂感染的儿科患者中达到15至20mg/L稳态谷浓度的发生率。

方法

我们对2009年7月1日至2011年6月30日期间入住我院儿童医院的患者进行了回顾性病历审查。纳入标准为年龄在1个月至18岁之间,至少获得1次万古霉素稳态谷浓度,接受每6小时一次、每次15mg/kg的初始万古霉素剂量治疗,且正在接受脑膜炎、肺炎、骨髓炎、菌血症/败血症或心内膜炎诊断治疗的患者。

结果

共纳入74例患者,平均年龄4.2±3.9岁,体重17.0±11.2kg。5例(6.8%)患者初始谷浓度为15至20mg/L。与其他评估年龄组相比,1.0至5.9岁的患者达到15至20mg/L初始谷浓度的可能性显著降低(P = 0.041)。34例初始谷浓度低于治疗水平的患者接受了剂量调整并进行了万古霉素谷浓度随访。在这些患者中,15例(44.1%)谷浓度达到15至20mg/L。在研究期间任何时间达到治疗性谷浓度的患者的中位剂量为每天80mg/kg。

结论

每6小时一次、每次15mg/kg的万古霉素给药方案不太可能使患有复杂感染的儿科患者的谷浓度达到15至20mg/L。对于这些患者,初始方案为每天80mg/kg可能更有可能导致万古霉素达到治疗性稳态浓度。

相似文献

1
An evaluation of vancomycin dosing for complicated infections in pediatric patients.儿童复杂感染患者万古霉素给药剂量的评估。
Hosp Pediatr. 2015 May;5(5):276-81. doi: 10.1542/hpeds.2014-0081.
2
Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.评估万古霉素在儿科患者中的给药剂量和随后的血清浓度。
Ann Pharmacother. 2011 May;45(5):582-9. doi: 10.1345/aph.1P588. Epub 2011 Apr 26.
3
A randomized controlled trial of a vancomycin loading dose in children.一项万古霉素负荷剂量在儿童中的随机对照试验。
Pediatr Infect Dis J. 2013 Nov;32(11):1217-23. doi: 10.1097/INF.0b013e3182a26774.
4
Empirical Vancomycin Dosing in Pediatric Patients with Congenital Heart Disease and the Impact of Cardiopulmonary Bypass on Trough Concentrations.先天性心脏病患儿经验性万古霉素给药及体外循环对谷浓度的影响。
Pharmacotherapy. 2017 Nov;37(11):1341-1346. doi: 10.1002/phar.2019. Epub 2017 Sep 28.
5
Vancomycin trough concentrations in overweight or obese pediatric patients.超重或肥胖儿科患者的万古霉素谷浓度。
Pharmacotherapy. 2013 Dec;33(12):1273-7. doi: 10.1002/phar.1321. Epub 2013 Jun 24.
6
Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.新生儿重症监护病房患者经验性给药时治疗性万古霉素血药谷浓度的达成情况。
Pediatr Infect Dis J. 2015 Jul;34(7):742-7. doi: 10.1097/INF.0000000000000664.
7
Performance of a divided-load intravenous vancomycin dosing strategy for critically ill patients.一种针对重症患者的分负荷静脉注射万古霉素给药策略的效果
Ann Pharmacother. 2013 Dec;47(12):1611-7. doi: 10.1177/1060028013510395. Epub 2013 Oct 25.
8
Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations.全院范围内增加经验性儿科万古霉素剂量对初始谷浓度的影响。
Pharmacotherapy. 2011 Sep;31(9):871-6. doi: 10.1592/phco.31.9.871.
9
Evaluation of the vancomycin dosage regimen based on serum creatinine used in the neonatal intensive care unit.基于新生儿重症监护病房使用的血清肌酐评估万古霉素给药方案。
Pediatr Int. 2011 Dec;53(6):1038-44. doi: 10.1111/j.1442-200X.2011.03441.x.
10
Individualized vancomycin dosing in obese patients: a two-sample measurement approach improves target attainment.肥胖患者的个体化万古霉素给药:双样本测量方法可提高目标达成率。
Pharmacotherapy. 2015 May;35(5):455-63. doi: 10.1002/phar.1588.

引用本文的文献

1
Practical approaches to improve vancomycin-related patient outcomes in pediatrics- an alternative strategy when AUC/MIC is not feasible.改善儿科患者万古霉素相关转归的实用方法- AUC/MIC 不可行时的替代策略。
BMC Pharmacol Toxicol. 2022 Aug 20;23(1):64. doi: 10.1186/s40360-022-00606-1.
2
Population pharmacokinetics and dose optimization of vancomycin in neonates.新生儿万古霉素群体药代动力学与剂量优化。
Sci Rep. 2021 Mar 17;11(1):6168. doi: 10.1038/s41598-021-85529-3.
3
Evaluation of vancomycin initial trough levels in children: A 1-year retrospective study.
儿童万古霉素初始谷浓度评估:一项为期1年的回顾性研究。
SAGE Open Med. 2020 Aug 25;8:2050312120951058. doi: 10.1177/2050312120951058. eCollection 2020.
4
Effect of Vancomycin Loading Doses on the Attainment of Target Trough Concentrations in Hospitalized Children.万古霉素负荷剂量对住院儿童目标谷浓度达标的影响。
J Pediatr Pharmacol Ther. 2020;25(5):423-430. doi: 10.5863/1551-6776-25.5.423.
5
Vancomycin Dosage and Its Association with Clinical Outcomes in Pediatric Patients with Gram-Positive Bacterial Infections.万古霉素剂量及其与革兰氏阳性菌感染儿科患者临床结局的关联。
Risk Manag Healthc Policy. 2020 Jun 29;13:685-695. doi: 10.2147/RMHP.S244836. eCollection 2020.
6
Vancomycin Dosing in Children With Overweight or Obesity: A Systematic Review and Meta-analysis.超重或肥胖儿童的万古霉素给药:系统评价与荟萃分析
Hosp Pediatr. 2020 Apr;10(4):359-368. doi: 10.1542/hpeds.2019-0287. Epub 2020 Mar 25.
7
Steady-state Pharmacokinetics of Vancomycin in Children Admitted to Pediatric Intensive Care Unit of a Tertiary Referral Center.三级转诊中心儿科重症监护病房收治儿童的万古霉素稳态药代动力学
Indian J Crit Care Med. 2019 Nov;23(11):497-502. doi: 10.5005/jp-journals-10071-23275.
8
Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections in Children: a Reappraisal of Vancomycin.儿童耐甲氧西林金黄色葡萄球菌(MRSA)感染的治疗:对万古霉素的重新评估
Curr Infect Dis Rep. 2019 Sep 5;21(10):37. doi: 10.1007/s11908-019-0695-4.
9
Vancomycin Use in a Paediatric Intensive Care Unit of a Tertiary Care Hospital.万古霉素在一家三级医院儿科重症监护病房的应用。
Paediatr Drugs. 2019 Aug;21(4):303-312. doi: 10.1007/s40272-019-00343-9.
10
Vancomycin Monotherapy May Be Insufficient to Treat Methicillin-resistant Staphylococcus aureus Coinfection in Children With Influenza-related Critical Illness.万古霉素单药治疗可能不足以治疗流感相关危重症合并耐甲氧西林金黄色葡萄球菌感染的儿童。
Clin Infect Dis. 2019 Jan 18;68(3):365-372. doi: 10.1093/cid/ciy495.